Clinical Course of Children with Campylobacter Gastroenteritis With and Without Co-Infection in Lima, Peru
Related Experiment Video
Updated: Sep 29, 2025

Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens
Published on: March 10, 2020
Galo Amaro Munoz1, Maribel Denise Riveros-Ramirez1,2, Elsa Chea-Woo1
1School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.
Insights
Coinfections with Campylobacter spp. in children aged 12-24 months often present with more severe symptoms than single infections. Macrolide treatment may offer faster recovery for severe coinfection cases.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Clinical Gastroenterology
Background:
- Gastroenteritis is a common childhood illness, with Campylobacter spp. being a significant pathogen.
- Understanding the clinical impact of single versus coinfections is crucial for effective treatment.
- Pediatric populations, particularly those aged 12-24 months, are vulnerable to severe diarrheal diseases.
Purpose of the Study:
- To compare the clinical presentation and outcomes of Campylobacter spp. gastroenteritis in single infections versus coinfections.
- To evaluate the impact of empirical antibiotic treatment, specifically macrolides, on clinical course.
- To analyze treatment responses in relation to infection type (single vs. coinfection) and severity.
Main Methods:
- Descriptive study of a pediatric cohort in Lima, Peru (2008-2011).
- Evaluation of 96 diarrheal episodes with positive Campylobacter spp. cultures.
- Analysis of clinical data including symptom duration, frequency of bowel movements, vomiting, and fever, stratified by infection type and treatment.
Main Results:
- Coinfections (64.6%) were more frequent than single infections, often involving Escherichia coli, norovirus, or Giardia.
- Coinfections exhibited longer symptom duration (6.6 vs. 5.7 days), higher bowel movement frequency (18.9 vs. 14.8), and increased rates of vomiting and fever compared to single infections.
- Patients with severe coinfections treated with macrolides showed a potential for faster recovery than those treated with non-macrolides.
Conclusions:
- Campylobacter spp. coinfections in young children generally lead to more severe gastroenteritis than single infections.
- Empirical macrolide treatment may be associated with improved clinical outcomes in severe cases of Campylobacter coinfection.
- Further research is warranted to confirm the efficacy of macrolides in managing severe pediatric Campylobacter coinfections.
Abstract:
This study describes the clinical course of gastroenteritis caused by Campylobacter spp. as a single-infection versus coinfection and the corresponding changes that occur according to the treatment received, in children between 12 and 24 months of age. This descriptive study is based on the data of a pediatric cohort conducted between 2008 and 2011 of 555 children in Lima, Peru. Ninety-six diarrheal episodes with positive cultures for Campylobacter spp. were evaluated. In 52 episodes, empirical antibiotic treatment was started before pathogen isolation. Of these 96 episodes, 64.6% were coinfections with other pathogens. Coinfections were led by Escherichia coli, norovirus, and Giardia. Compared with single-infection episodes, coinfections had a mean symptom duration of 6.6 versus 5.7 days, a mean frequency of bowel movements per episode of 18.9 versus 14.8, and occurrence of vomiting and fever in 24.2% versus 14.7% of patients. Most of the patients with more severe clinical features at diagnosis were prescribed macrolides as empiric treatment. In the single-infection group, symptom duration was 7.2 ± 3.3 days in the macrolide-treated group and 7.9 ± 2.7 days in the nonmacrolide group. Diarrhea caused by coinfection appeared to be generally more severe than a single-pathogen. Patients with more severe clinical courses who received macrolides treatment might have had a faster recovery than patients who received nonmacrolides.
More Related Videos
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Stages of Infection
Acute Pyelonephritis I: Introduction
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Endocarditis II: Clinical Features of Infective Endocarditis
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.

